glp-1 receptor agonists effects on cardiovascular risk reduction and mortality outcomes with vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia GLP-1 receptor agonists confer 'modest'

Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, Kington RS, Lane NE, Nevitt MC, Zhang Y, Sowers M, McAlindon T, Spector TD, Poole AR, Yanovski SZ, Ateshian G, Sharma L, Buckwalter JA, Brandt KD, Fries JF (2000) Osteoarthritis: new insights

The numbers tell the story: patients on these medications have higher rates of retained gastric contents during esophagogastroduodenoscopy (EGD) compared to non-users 8.07% versus 3.49% [14]

The study highlighted that eggs do not have a major impact on overall cholesterol levels

51 Addressing these adverse effects is crucial for improving patient compliance and therapeutic outcomes

A.EvansA.EidN.Sadeghi-NejadH.et al (2023)